Body fluid analysis

Body Fluids
BodyFluid.ppt

Pleural, Peritoneal, Pericardial Fluids
BFSerous.ppt

Synovial Fluid
BFSynovial.ppt

Blood Borne Pathogens
Blood Borne Pathogens.ppt

Introduction to Forensic Science and Criminalistics
Peter Bilous
Biological Evidence Serology.ppt

Medical Laboratory Science - The Hidden Profession
Kimberly A. Whiter MLS
MLSProfessionPresentation.ppt

Role of Body Fluid Volume Regulation
Robert W. Schrier, MD
Role of Body Fluid Volume Regulation.ppt

ASSESSMENT OF NUTRITIONAL STATUS
Abdelaziz Elamin, MD, PhD, FRCPCH
ASSESSMENT OF NUTRITIONAL STATUS.ppt

Bloodborne Pathogen Training
BloodbornePathogenTraining.ppt

Forensic DNA Analysis
Forensic DNA Analysis.ppt

The Impaired Physician Focus on Substance Abuse
Michael J. Reichgott, MD, PhD
Focus on Substance Abuse.ppt

The Effects of the Menstrual and Lunar Cycles on Body Fluid Balance
Amy J. Reckard LAT, ATC
Menstrual and Lunar Cycles on Body Fluid Balance.ppt

Blood and body fluid exposures
ohcExposureBBF.ppt

Bloodborne Pathogens
Bloodborne Pathogens.ppt

Identification of Biological Fluids and Stains
EBiolFluids.ppt

Bloodborne Pathogens (BBPs)
BBPS.ppt

FLUID AND ELECTROLYTES
FLUID AND ELECTROLYTES.ppt

Forensic Serology Identification Using Blood Groups
Forensic Serology Identification.ppt

FLUID, ELECTROLYTE, AND ACID-BASE BALANCE
FLUID, ELECTROLYTE, AND ACID-BASE BALANCE.PPT

Human DNA Quantification using qPCR
Human DNA Quantification using qPCR.ppt

Introduction to Clinical Laboratory Practices
UASedCrystals.ppt

AIDS/HIV UPDATE
Neal R. Chamberlain, Ph.D
AIDSupdate.ppt
Latest 10 published articles

Read more...

Humoral Immunity

The term humoral refers to the non-cellular components of the blood, such as plasma and lymphatic fluid. The humoral immune response denotes immunologic responses that are mediated by antibodies.

Humoral Immunity
Humoral Immunity.ppt

Humoral Immunity Antibodies
Humoral Immunity Antibodies.ppt

Humoral Immune Response
Terry Kotrla, MS, MT(ASCP)BB
HumoralImmuneResponse.ppt
HumoralImmuneResponseFall2010.ppt

Effector Mechanisms of Humoral Immunity
Effector Mechanisms of Humoral Immunity.ppt

Immunity mediated by B-lymphocytes and Antibodies
Immunity mediated by B-lymphocytes and Antibodies.ppt

The Immune System: Innate and Adaptive Body Defenses
The Immune System.ppt

The Immune system
The Immune System.ppt

Adaptive/Acquired Immunity
Adaptive_Immunity2.ppt

Specific Host Defenses: The Immune Response
SpecificDefenses.ppt

The Body’s Defenses
Immunity.ppt

Acquired – Specific – Adaptive Immunity
Acquired – Specific – Adaptive Immunity.ppt

Immunity Body Defenses
ImmunityF07.ppt

Immune System
Daryl Beatty
Immune System.ppt

DNA Vaccines
DNA Vaccines.ppt

Adaptive Immunity: Specific Defenses of the Host
Adaptive Immunity.ppt

Immunity and Cell Defense
Lukasz Stelinski
Immunity and Cell Defense.ppt

Humoral Immune Response
Humoral Immune Response.ppt

Adaptive Immune Response
Adaptive Immune Response.ppt

The Immune System
immune.ppt

Immunity and Autoimmune Disease
Jessica Rando
Immunologyfinal.ppt

Immune Response and Immunity
Mark D. Sobsey
Immune Response and Immunity.ppt

Humoral Immunity: B Cells
SpecificResistII.ppt

Immunity – The War Against Infection
Immunity – The War Against Infection.ppt

Lymphatics and the Immune System
Lymphatics and the Immune System.ppt
Published articles on humoral immunity Free access

Read more...

Voiding Dysfunction

Voiding Dysfunction is a general term to describe the condition where there is a lack of coordination between the bladder muscle (detrusor) and the urethra. With normal urination, the urethra relaxes and opens when the bladder muscle contracts allowing urine to pass out of the body freely. In those with voiding dysfunction, the urethra does not relax when the bladder muscle contracts making it difficult for urine to pass.

Management of Patients With Upper or Lower Urinary Tract Dysfunction
Mrs.Mahdia Samaha Kony
Renal incontinence.ppt
Part-2 by Miss Iman Shaweesh
Renal incontinece-2.ppt

Pediatric GU Dysfunction
Pediatric GU Dysfunction.ppt

Common Genitourinary Disorders
Common Genitourinary Disorders .ppt

Urinary Incontinence in Older Adults
Tomas L. Griebling, MD, MPH
Urinary Incontinence in Older Adults.ppt

Urinary Tract Infections Diagnosis and Management
Tristan T. Berry,
Fungal_GR.PPT

Neurogenic Bladder Dysfunction
Sean Collins, M.D.
Neurogenic_Bladder_Dysfunction.ppt

Urine & Body Fluid Analysis Renal Disease
Ricki Otten MT(ASCP)SC
Urine & Body Fluid Analysis Renal Disease.ppt

Toileting: The Assessment and Treatment of Enuresis and Encopresis
Emily D. Warnes, Ph.D.
ToiletingEnuresisandEncopresisNoPic.ppt

Neurological and Medical Complication of Stroke
Harvey A. Drapkin, D.O. F.A.C.N.
Neurological and Medical Complication.ppt

Genitourinary dysfunction
Genitourinary dysfunction.ppt

Common Prepubescent Gynecological Issues
D’Juanna White Satcher MD MPH
http://www.bcm.edu/web/pediatrics/documents/nc_archive_64.ppt

Genital-Urinary System
Genital-Urinary System-1.ppt
Genital-Urinary System-2.ppt

Evaluation and Treatment of Urinary Incontinence and Prolapse
Prolapse.ppt

Renal & Urologic Problems
Urologic Problems.ppt

Alterations of GI System
GI System.ppt

Genitourinary
Elisa A. Mancuso RNC-NIC, MS, FNS
Genitourinary.ppt

Genitourinary Disorders
Jan Bazner-Chandler
Genitourinary Disorders.ppt

Incontinence - Urinary and Fecal
Incontinence - Urinary and Fecal.ppt

Drug Treatment Choice in Older Adults with Urinary Incontinence
Catherine E. DuBeau, MD
Urinary Incontinence.ppt

Urinary Elimination
Urinary Elimination.ppt
53 Free full text articles 

1. Predictors of Voiding Dysfunction after Mid-urethral Sling Surgery for Stress Urinary Incontinence.
2. Patients with a history of infection and voiding dysfunction are at risk for recurrence after successful endoscopic treatment of vesico ureteral reflux and deserve long-term follow up.
3. Helping patients with voiding dysfunction: What are our current options?
4. Clinical, imaging and cystometric findings of voiding dysfunction in children.
5. Percutaneous intervention of large bladder calculi in neuropathic voiding dysfunction.
6. Voiding dysfunction after total mesorectal excision in rectal cancer.
7. Voiding dysfunction after pelvic colorectal surgery.
8. Role of Purinergic Signaling in Voiding Dysfunction.
9. Pharmacokinetic study of nicotine and its metabolite cotinine to clarify possible association between smoking and voiding dysfunction in rats using UPLC/ESI-MS.
10. Rethinking suprapubic cystostomy in voiding dysfunction: new trial with timed drainage.
11. Predictors of Postoperative Voiding Dysfunction following Transobsturator Sling Procedures in Patients with Stress Urinary Incontinence.
12. Treatment of urinary voiding dysfunction syndromes with spinal cord stimulation.
13. The forefront for novel therapeutic agents based on the pathophysiology of lower urinary tract dysfunction: alpha-blockers in the treatment of male voiding dysfunction - how do they work and why do they differ in tolerability?
14. The forefront for novel therapeutic agents based on the pathophysiology of lower urinary tract dysfunction: pathophysiology of voiding dysfunction and pharmacological therapy.
15. Voiding dysfunction after brachytherapy in patients with prostate cancer.
16. Voiding dysfunction in prostate cancer.
17. Voiding dysfunction in prostate cancer.
18. Efficacy and safety of tamsulosin for the treatment of non-neurogenic voiding dysfunction in females: a 8-week prospective study.
19. Role of voiding and storage symptoms for the quality of life before and after treatment in men with voiding dysfunction.
20. Social stress in mice induces voiding dysfunction and bladder wall remodeling.
21. Voiding dysfunction due to multiple sclerosis: a large scale retrospective analysis.
22. Hormone replacement therapy has no routine role in the management of postmenopausal voiding dysfunction.
23. Should hormone replacement therapy be used in postmenopausal women for voiding dysfunction?
24. Effect of Goshajinkigan on storage symptoms in prostatic disease--fundamental researches of Chinese herbal medicine for voiding dysfunction and its future aspects.
25. Early versus late treatment of voiding dysfunction with pelvic neuromodulation.
26. The potential of hormones and selective oestrogen receptor modulators in preventing voiding dysfunction in rats.
27. Prevalence and characteristics of late postoperative voiding dysfunction in early-stage cervical cancer patients treated with radical hysterectomy.
28. Evaluation of purinergic mechanism for the treatment of voiding dysfunction: a study in conscious spinal cord-injured rats.
29. Effects of thyrotropin-releasing hormone on urethral closure pressure in females with voiding dysfunction.
30. Urodynamic features of the voiding dysfunction in HTLV-1 infected individuals.
31. Conservative management of voiding dysfunction.
32. Effectiveness of tolterodine in nonneurogenic voiding dysfunction.
33. Is There a Role for alpha-Blockers for the Treatment of Voiding Dysfunction Unrelated to Benign Prostatic Hyperplasia?
34. Evaluation of voiding dysfunction and measurement of bladder volume.
35. Sacral nerve stimulation for the management of voiding dysfunction.
36. Risk factors of voiding dysfunction and patient satisfaction after tension-free vaginal tape procedure.
37. Combined use of alpha-adrenergic and muscarinic antagonists for the treatment of voiding dysfunction.
38. Investigation of voiding dysfunction in a population-based sample of children aged 3 to 9 years.
39. Voiding dysfunction and urodynamic abnormalities in elderly patients.
40. Neurogenic voiding dysfunction after sacrococcygeal teratoma resection.
41. Sonographic findings in a case of voiding dysfunction secondary to the tension-free vaginal tape (TVT) procedure.
42. Ultrasound diagnosis of intra-urethral tension-free vaginal tape (TVT) position as a cause of postoperative voiding dysfunction and retropubic pain.
43. Voiding dysfunction in women with systemic lupus erythematosus.
44. Voiding dysfunction in Duchenne muscular dystrophy.
45. Vesicoureteric reflux and functional voiding dysfunction in children.
46. Assessment of voiding dysfunction in Parkinson's disease by the international prostate symptom score.
47. Experimental study of voiding dysfunction induced by cerebral infarction in rats.
48. Voiding dysfunction in brain disease.
49. Voiding dysfunction after abdominal radical hysterectomy. Comparison between patients with and without adjuvant irradiation therapy.
50. Improvement of urethral resistance after the administration of an alpha-adrenoceptor blocking agent, urapidil, for neuropathic voiding dysfunction.
51. Voiding dysfunction in patients with human T-lymphotropic virus type-1-associated myelopathy (HAM).
52. Clinical evaluation for voiding dysfunction in patients with cerebral-palsy.
53. Abnormal electromyographic activity of the urethral sphincter, voiding dysfunction, and polycystic ovaries: a new syndrome?

Read more...